Barclays’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-99,739
| Closed | -$72K | – | 4602 |
|
|
2025
Q1 | $72K | Buy |
99,739
+88,715
| +805% | +$64K | ﹤0.01% | 3790 |
|
|
2024
Q4 | $12K | Hold |
11,024
| – | – | ﹤0.01% | 4169 |
|
|
2024
Q3 | $8K | Sell |
11,024
-14,727
| -57% | -$10.7K | ﹤0.01% | 4163 |
|
|
2024
Q2 | $25K | Sell |
25,751
-12,724
| -33% | -$12.4K | ﹤0.01% | 3870 |
|
|
2024
Q1 | $91K | Sell |
38,475
-13,605
| -26% | -$32.2K | ﹤0.01% | 3672 |
|
|
2023
Q4 | $117K | Buy |
52,080
+44,857
| +621% | +$101K | ﹤0.01% | 3681 |
|
|
2023
Q3 | $16K | Sell |
7,223
-328
| -4% | -$727 | ﹤0.01% | 3949 |
|
|
2023
Q2 | $23K | Buy |
+7,551
| New | +$23K | ﹤0.01% | 3947 |
|
|
2022
Q2 | – | Sell |
-3,083
| Closed | -$19K | – | 4933 |
|
|
2022
Q1 | $19K | Buy |
+3,083
| New | +$19K | ﹤0.01% | 4350 |
|